Related references
Note: Only part of the references are listed.PI3Kγ Mediates Kaposi's Sarcoma-Associated Herpesvirus vGPCR-Induced Sarcomagenesis
Daniel Martin et al.
CANCER CELL (2011)
New phosphatidylinositol 3-kinase inhibitors for cancer
Daniel W. Bowles et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial-Mesenchymal Transition in HCC Cells
Ai-Wu Ke et al.
GASTROENTEROLOGY (2011)
p28(GANK) Overexpression Accelerates Hepatocellular Carcinoma Invasiveness and Metastasis via Phosphoinositol 3-Kinase/AKT/Hypoxia-Inducible Factor-1 alpha Pathways
Jing Fu et al.
HEPATOLOGY (2011)
Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
Xuxiao Zhang et al.
MOLECULAR CELL (2011)
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
Alyssa L. Kennedy et al.
MOLECULAR CELL (2011)
Vimentin is a novel AKT1 target mediating motility and invasion
Q-S Zhu et al.
ONCOGENE (2011)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
Tong T. Zhao et al.
PLOS ONE (2010)
Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase
Huan Pang et al.
CANCER RESEARCH (2009)
The regulation and function of Class III PI3Ks: novel roles for Vps34
Jonathan M. Backer
BIOCHEMICAL JOURNAL (2008)
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase
Jeffrey D. Carson et al.
BIOCHEMICAL JOURNAL (2008)
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract
Marc-Oliver Riener et al.
GENES CHROMOSOMES & CANCER (2008)
Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab
Shizhen Emily Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations
Chuan-Hsiang Huang et al.
SCIENCE (2007)
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme
Gary L. Gallia et al.
MOLECULAR CANCER RESEARCH (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Autophagy signaling and the cogwheels of cancer
Joelle Botti et al.
AUTOPHAGY (2006)
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 30H-kinase
T Nobukuni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The role of autophagy in cancer development and response to therapy
Y Kondo et al.
NATURE REVIEWS CANCER (2005)
Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2
SQ Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway
S Arico et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphoinositide signaling and the regulation of membrane trafficking in yeast
G Odorizzi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells
A Petiot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)